Information for "Section 3.5: Treatment (from DOI: 10.1080/22221751.2020.1735265)"

Basic information

Display title	Section 3.5: Treatment (from DOI: 10.1080/22221751.2020.1735265)
Default sort key	Section 3.5: Treatment (from DOI: 10.1080/22221751.2020.1735265)
Page length (in bytes)	523
Page ID	12466
Page content language	en - English
Page content model	wikitext
Indexing by robots	Allowed
Number of redirects to this page	0
Counted as a content page	Yes
Wikibase.slis.ua.edu item ID	Q8408
Central description	Publication: "Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection" in the journal Emerg Microbes Infect (2020); DOI: 10.1080/22221751.2020.1735265

Page protection

Edit	Allow all users (infinite)
Move	Allow all users (infinite)

View the protection log for this page.

Edit history

Page creator	Maintenance script (talk \| contribs)
Date of page creation	19:05, 14 May 2020
Latest editor	Admin (talk \| contribs)
Date of latest edit	19:24, 14 May 2020
Total number of edits	2
Total number of distinct authors	2
Recent number of edits (within past 90 days)	0
Recent number of distinct authors	0

Page properties

Transcluded templates (6)	Templates used on this page: Template:Infobox (view source) Template:Infobox publicationsection (view source) Template:Template other (view source) Module:Entity (view source) Module:Infobox (view source) Module:Navbar (view source)
Wikibase.slis.ua.edu entities used in this page	occurs in Label: en Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0) (DOI: 10.1080/22221751.2020.1735265) Title Label: en Section 1: Introduction (from DOI: 10.1080/22221751.2020.1735265) Title Section 2: Protection requirements of medical personnel (from DOI: 10.1080/22221751.2020.1735265) Title Section 2.1: Selection of front-line personnel (from DOI: 10.1080/22221751.2020.1735265) Title Section 2.2: Isolation and protection requirements (from DOI: 10.1080/22221751.2020.1735265) Title Section 2.3: Isolation and observation of medical personnel after close contact with SARS-CoV-2 (from DOI: 10.1080/22221751.2020.1735265) Title Section 3: Diagnosis and treatment of SARS-CoV-2 infected patients (from DOI: 10.1080/22221751.2020.1735265) Title Section 3.1: Screening criteria (from DOI: 10.1080/22221751.2020.1735265) Title Section 3.2: Diagnostic criteria (from DOI: 10.1080/22221751.2020.1735265) Title Section 3.3: Examination routines of SARS-CoV-2 infected patient (from DOI: 10.1080/22221751.2020.1735265) Title Section 3.3.1: Screening cases on the day of visit (from DOI: 10.1080/22221751.2020.1735265) Title Section 3.3.2: Sequential examination of confirmed patients (from DOI: 10.1080/22221751.2020.1735265) Title Section 3.4: Place of treatment according to the severity of the disease (from DOI: 10.1080/22221751.2020.1735265) Title Section 3.4.1: Severe type (from DOI: 10.1080/22221751.2020.1735265) Title Section 3.4.2: Critically ill type (from DOI: 10.1080/22221751.2020.1735265) Title Section 3.5: Treatment (from DOI: 10.1080/22221751.2020.1735265) Title Statement: P146 Statement: P94 Other (Statements) Sitelink Statement: P78 Statement: P125 Section 3.5.1: General treatment (from DOI: 10.1080/22221751.2020.1735265) Title Section 3.5.2: Oxygen therapy (from DOI: 10.1080/22221751.2020.1735265) Title Section 3.5.2.1: Choice of oxygen therapy (from DOI: 10.1080/22221751.2020.1735265) Title Section 3.5.2.2: The way of respiratory support (from DOI: 10.1080/22221751.2020.1735265) Title Section 3.5.3: Antiviral treatment (from DOI: 10.1080/22221751.2020.1735265) Title Section 3.5.4: Glucocorticoid therapy (from DOI: 10.1080/22221751.2020.1735265) Title Label: en Section 3.5.5: Intravenous immunoglobulin (from DOI: 10.1080/22221751.2020.1735265) Title Section 3.5.6: Empirical antimicrobial therapy (from DOI: 10.1080/22221751.2020.1735265) Title Section 4: Protection and transfer (from DOI: 10.1080/22221751.2020.1735265) Title Section 5: Criteria of isolation release and discharge (from DOI: 10.1080/22221751.2020.1735265) Title

Information for "Section 3.5: Treatment (from DOI: 10.1080/22221751.2020.1735265)"

Basic information

Page protection

Edit history

Page properties

Navigation menu

Personal tools

Namespaces

Variants

Views

More

Search

Navigation

Tools